Economics at your fingertips  

Applied Health Economics and Health Policy

2008 - 2017

Current editor(s): Timothy Wrightson

From Springer
Series data maintained by Sonal Shukla ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 15, issue 4, 2017

We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs pp. 437-440 Downloads
Anna Månsdotter, Björn Ekman, Inna Feldman, Lars Hagberg, Anna-Karin Hurtig and Lars Lindholm
Clinical, Economic and Policy Implications of Drug Shortages in the European Union pp. 441-445 Downloads
Elfi De Weerdt, Steven Simoens, Minne Casteels and Isabelle Huys
Drug Pricing in South Korea pp. 447-453 Downloads
Hye-Young Kwon and Brian Godman
Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance pp. 455-468 Downloads
Iain Willits, Helen Cole, Roseanne Jones, Kimberley Carter, Mick Arber, Michelle Jenks, Joyce Craig and Andrew Sims
A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? pp. 469-477 Downloads
Emma Cowles, Grace Marsden, Amanda Cole and Nancy Devlin
Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy pp. 479-490 Downloads
M. Ruggeri, M. Basile, S. Coretti, Carlo Drago and A. Cicchetti
Estimating Willingness to Pay for Online Health Services with Discrete-Choice Experiments pp. 491-500 Downloads
Jieun Chang, Scott J. Savage and Donald M. Waldman
Cost‐Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy pp. 501-512 Downloads
Ana Teresa Paquete, Luís Silva Miguel, Ursula Becker, Catarina Pereira and Carlos Gouveia Pinto
The Medicaid Rebate: Changes in Oncology Drug Prices After the Affordable Care Act pp. 513-520 Downloads
Ali Bonakdar Tehrani and Norman V. Carroll
Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia pp. 521-534 Downloads
Barbara Graaff, Amanda Neil, Lei Si, Kwang Chien Yee, Kristy Sanderson, Lyle Gurrin and Andrew J. Palmer
Comment on: “Measuring the Volume–Outcome Relation for Complex Hospital Surgery” pp. 535-536 Downloads
Harold S. Luft
Authors’ Reply to Luft: “Measuring the Volume-Outcome Relation for Complex Hospital Surgery” pp. 537-538 Downloads
Vivian Ho, Woohyeon Kim and Stephen Wolff
Erratum to: Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance pp. 539-539 Downloads
Iain Willits, Helen Cole, Roseanne Jones, Kimberley Carter, Mick Arber, Michelle Jenks, Joyce Craig and Andrew Sims

Volume 15, issue 3, 2017

Aligning Health Economics Methods to Fit with the Changing World of Public Health pp. 287-289 Downloads
Emma Frew
Malaria and Economic Evaluation Methods: Challenges and Opportunities pp. 291-297 Downloads
Tom L. Drake and Yoel Lubell
Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy pp. 299-306 Downloads
Tom L. Drake, Yoel Lubell, Shwe Sin Kyaw, Angela Devine, Myat Phone Kyaw, Nicholas P. J. Day, Frank M. Smithuis and Lisa J. White
How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries pp. 307-321 Downloads
Sabine Vogler, Valérie Paris, Alessandra Ferrario, Veronika J. Wirtz, Kees Joncheere, Peter Schneider, Hanne Bak Pedersen, Guillaume Dedet and Zaheer-Ud-Din Babar
Screen Time and Health Indicators Among Children and Youth: Current Evidence, Limitations and Future Directions pp. 323-331 Downloads
Travis J. Saunders and Jeff K. Vallance
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review pp. 333-351 Downloads
Irmgard C. Schiller-Frühwirth, Beate Jahn, Marjan Arvandi and Uwe Siebert
Does Insurance Status Influence a Patient’s Hospital Charge? pp. 353-362 Downloads
Lindsey Woodworth, Patrick S. Romano and James F. Holmes
Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective pp. 363-374 Downloads
Zanfina Ademi, Kumar Pasupathi and Danny Liew
Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives pp. 375-384 Downloads
Katharine S. Gries, Dean A. Regier, Scott D. Ramsey and Donald L. Patrick
Can a Circular Payment Card Format Effectively Elicit Preferences? Evidence From a Survey on a Mandatory Health Insurance Scheme in Tunisia pp. 385-398 Downloads
Olivier Chanel, Khaled Makhloufi and Mohammad Abu-Zaineh
An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care pp. 399-412 Downloads
Julie Ratcliffe, Thomas Flint, Tiffany Easton, Maggie Killington, Ian Cameron, Owen Davies, Craig Whitehead, Susan Kurrle, Michelle Miller, Enwu Liu and Maria Crotty
Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease pp. 413-424 Downloads
Sabrina Storgaard Sørensen, Kjeld Møller Pedersen, Ulla Møller Weinreich and Lars Ehlers
Assessing Equity in the Provision of Primary Healthcare Centers in Buenos Aires Province (Argentina): A Stochastic Frontier Analysis pp. 425-433 Downloads
Florencia Arnaudo, Fernando Lago and Valentina Viego
Erratum to: Malaria and Economic Evaluation Methods: Challenges and Opportunities pp. 435-435 Downloads
Tom L. Drake and Yoel Lubell

Volume 15, issue 1, 2017

‘Appropriateness’ in Italy: A ‘Magic Word’ in Pharmaceuticals? pp. 1-3 Downloads
Livio Garattini and Anna Padula
The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements pp. 5-11 Downloads
Mondher Toumi, Szymon Jarosławski, Toyohiro Sawada and Åsa Kornfeld
Economic Crisis, Austerity Policies, Health and Fairness: Lessons Learned in Spain pp. 13-21 Downloads
Beatriz G. Lopez-Valcarcel and Patricia Barber
Health State Utility Values for Age-Related Macular Degeneration: Review and Advice pp. 23-32 Downloads
Thomas Butt, Adnan Tufail and Gary Rubin
Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers pp. 33-43 Downloads
Elias Asfaw Zegeye, Josue Mbonigaba, Sylvia Blanche Kaye and Thomas Wilkinson
Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data pp. 45-55 Downloads
Istvan Majer, Gijs Wetering, Zoltan Polanyi, Arun Krishna, Elisabeth Gray and Anuja Roy
Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China pp. 57-64 Downloads
Yuqing Tang, Chaojie Liu and Xinping Zhang
Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease pp. 65-74 Downloads
Andrew J. Leidner, Harrell W. Chesson, Philip R. Spradling and Scott D. Holmberg
The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients pp. 75-83 Downloads
Yue Zhong, Joshua T. Cohen, Scott Goates, Menghua Luo, Jeffrey Nelson and Peter J. Neumann
Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications pp. 85-93 Downloads
Marina Kostić, Ljiljan Djakovic, Raša Šujić, Brian Godman and Slobodan M. Janković
A Cost-Utility Analysis of Prostate Cancer Screening in Australia pp. 95-111 Downloads
Andrew Keller, Christian Gericke, Jennifer A. Whitty, John Yaxley, Boon Kua, Geoff Coughlin and Troy Gianduzzo
Promoting Antibacterial Drug Development: Select Policies and Challenges pp. 113-118 Downloads
Aylin Sertkaya, Amber Jessup and Hui-Hsing Wong

Volume 14, issue 6, 2016

Review of Economic Submissions to NICE Medical Technologies Evaluation Programme pp. 623-634 Downloads
Abualbishr Alshreef, Michelle Jenks, William Green and Simon Dixon
Parafricta Bootees and Undergarments to Reduce Skin Breakdown in People with or at Risk of Pressure Ulcers: A NICE Medical Technologies Guidance pp. 635-646 Downloads
Catherine Meads, Matthew Glover, Paul Dimmock and Subhash Pokhrel
Possible Impact of Incremental Cost-Effectiveness Ratio (ICER) on Decision Making for Cancer Screening in Hong Kong: A Systematic Review pp. 647-657 Downloads
Carlos K. H. Wong, Brian H. H. Lang, Vivian Y. W. Guo and Cindy L. K. Lam
A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines pp. 659-672 Downloads
Kittiphong Thiboonboon, Benjarin Santatiwongchai, Varit Chantarastapornchit, Waranya Rattanavipapong and Yot Teerawattananon
India’s Proposed Universal Health Coverage Policy: Evidence for Age Structure Transition Effect and Fiscal Sustainability pp. 673-690 Downloads
Muttur Ranganathan Narayana
Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany pp. 691-701 Downloads
Florian Hofer, Dmitrij Achelrod and Tom Stargardt
The Cost and Outcome Effectiveness of Total Hip Replacement: Technique Choice and Volume–Output Effects Matter pp. 703-718 Downloads
Jonathan P. Goldstein, George M. Babikian, Adam J. Rana, Johanna A. Mackenzie and Andrew Millar
Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands pp. 719-727 Downloads
Vassilis Fragoulakis, Chris P. Pescott, Jesper M. J. Smeenk, Evert J. P. Santbrink, G. Jur E. Oosterhuis, Frank J. M. Broekmans and Nikos Maniadakis
Comment on: “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review” pp. 729-730 Downloads
Afschin Gandjour
Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review” pp. 731-732 Downloads
Suzanne Laplante, Frank X. Liu, Bruce Culleton, Angelito Bernardo, Denise King and Pollyanna Hudson
A Review of “Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course” pp. 733-734 Downloads
Ahmed Abdulla and Angela Stainthorpe

Volume 14, issue 5, 2016

Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers? pp. 507-509 Downloads
Afschin Gandjour
Supporting Medicare Health, Equity and Efficiency in Australia: Policies Undermining Bulk Billing Need to Be Scrapped pp. 511-514 Downloads
Simon Eckermann and Lynnaire Sheridan
The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance pp. 515-526 Downloads
Alistair Ray, Helen Morgan, Antony Wilkes, Kimberley Carter and Grace Carolan-Rees
Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review pp. 527-543 Downloads
Miriam Luhnen, Siw Waffenschmidt, Andreas Gerber-Grote and Gloria Hanke
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK pp. 545-558 Downloads
Stephen Montgomery, Jeanette Kusel, Felicity Allen and Nicholas Adlard
A Qualitative Evaluation of Program Budgeting and Marginal Analysis in a Canadian Pediatric Tertiary Care Institution pp. 559-568 Downloads
Neale Smith, Craig Mitton, Mary-Ann Hiltz, Matthew Campbell, Laura Dowling, J. Fergall Magee and Shashi Ashok Gujar
Barrier to Access or Cost Share? Coinsurance and Dental-Care Utilization in Colombia pp. 569-578 Downloads
Lucas Higuera Jaramillo and Sergio Prada
Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal pp. 579-594 Downloads
M. Reza Maleki-Yazdi, Mathieu Molimard, Dorothy L. Keininger, Jean-Bernard Gruenberger, Joao Carrasco, Claudia Pitotti, Elsa Sauvage, Sara Chehab and David Price
Care Appropriateness and Health Productivity Evolution: A Non-Parametric Analysis of the Italian Regional Health Systems pp. 595-607 Downloads
Paolo Mancuso and Vivian Valdmanis
Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion pp. 609-617 Downloads
Katherine M. Prioli, Laura T. Pizzi, Julie Katz Karp, Taki Galanis and Jay H. Herman

Volume 14, issue 4, 2016

The Potential Impact of the Trans-Pacific Partnership Agreement on Health Equity, with Illustration From New Zealand pp. 397-400 Downloads
Gay Keating, Rhys Jones, Erik Monasterio and Josh Freeman
Governments Need Better Guidance to Maximise Value for Money: The Case of Australia’s Pharmaceutical Benefits Advisory Committee pp. 401-407 Downloads
Drew Carter, Arlene Vogan and Hossein Haji Ali Afzali
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review pp. 409-418 Downloads
Adam J. N. Raymakers, John Mayo, Stephen Lam, J. Mark FitzGerald, David G. T. Whitehurst and Larry D. Lynd
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups pp. 419-429 Downloads
Huanxue Zhou, Christopher Taber, Steve Arcona and Yunfeng Li
Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses pp. 431-440 Downloads
Manal H. El-Hamamsy, Gihan H. Elsisi, Randa Eldessouki, Mohamed M. Elmazar, Ahmed S. Taha, Basma F. Awad and Hossam Elmansy
Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany pp. 441-452 Downloads
I. Aumann, M. Treskova, N. Hagemann and J.-M. Schulenburg
Measuring the Volume-Outcome Relation for Complex Hospital Surgery pp. 453-464 Downloads
Woohyeon Kim, Stephen Wolff and Vivian Ho
Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain pp. 465-477 Downloads
Eliazar Sabater, Armando López-Guillermo, Antonio Rueda, Antonio Salar, Itziar Oyagüez and Juan Manuel Collar
The Efficiency of Increasing the Capacity of Physiotherapy Screening Clinics or Traditional Medical Services to Address Unmet Demand in Orthopaedic Outpatients: A Practical Application of Discrete Event Simulation with Dynamic Queuing pp. 479-491 Downloads
L. Standfield, T. Comans, M. Raymer, S. O’Leary, N. Moretto and P. Scuffham
A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence pp. 493-505 Downloads
Philippe Laramée, Aurélie Millier, Nora Rahhali, Olivier Cristeau, Samuel Aballéa, Clément François, Ylana Chalem, Mondher Toumi and Jürgen Rehm

Volume 14, issue 3, 2016

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? pp. 245-252 Downloads
Mark Jit and Raymond Hutubessy
Choice Experiments to Quantify Preferences for Health and Healthcare: State of the Practice pp. 253-266 Downloads
Axel Mühlbacher and F. Reed Johnson
The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology Guidance pp. 267-279 Downloads
Andrew Cleves, Paul Dimmock, Neil Hewitt and Grace Carolan-Rees
Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand pp. 281-292 Downloads
Unchalee Permsuwan, Nathorn Chaiyakunapruk, Piyameth Dilokthornsakul, Kednapa Thavorn and Surasak Saokaew
Key Aspects of a Sustainable Health Insurance System in Germany pp. 293-312 Downloads
Matthias Pelster, Vera Hagemann and Franziska Laporte Uribe
Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation pp. 313-322 Downloads
Amy Tawfik, Walter P. Wodchis, Petros Pechlivanoglou, Jeffrey Hoch, Don Husereau and Murray Krahn
Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis pp. 323-335 Downloads
Yuko Saruta and Jaume Puig-Junoy
Measuring Efficiency of Health Systems of the Middle East and North Africa (MENA) Region Using Stochastic Frontier Analysis pp. 337-347 Downloads
Samer Hamidi and Fevzi Akinci
The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations pp. 349-359 Downloads
Ali Moghtaderi and Scott Adams
Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA pp. 361-373 Downloads
Ken O’Day, Wayne C. Levy, Meridith Johnson and Arnold F. Jacobson
Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making pp. 375-385 Downloads
Takeru Shiroiwa, Shinya Saito, Kojiro Shimozuma, Satoshi Kodama, Shinichi Noto and Takashi Fukuda
Cost Implications for Subsequent Perinatal Outcomes After IVF Stratified by Number of Embryos Transferred: A Five Year Analysis of Vermont Data pp. 387-395 Downloads
Olivia J. Carpinello, Peter R. Casson, Chia-Ling Kuo, Renju S. Raj, E. Scott Sills and Christopher A. Jones

Volume 14, issue 2, 2016

A Review of “The New Drug Reimbursement Game: A Regulator’s Guide to Playing and Winning” pp. 127-128 Downloads
Christopher J. McCabe
The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling pp. 129-133 Downloads
George A. K. Voorn, Pepijn Vemer, Dominique Hamerlijnck, Isaac Corro Ramos, Geertruida J. Teunissen, Maiwenn Al and Talitha L. Feenstra
Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance pp. 135-149 Downloads
Michelle Jenks, Joyce Craig, William Green, Neil Hewitt, Mick Arber and Andrew Sims
A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis pp. 151-159 Downloads
Ilene L. Hollin and Karen A. Robinson
A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health pp. 161-183 Downloads
Elizabeth Goodwin and Colin Green
The Cost Effectiveness of High-Dose versus Conventional Haemodialysis: a Systematic Review pp. 185-193 Downloads
S. Laplante, F. X. Liu, B. Culleton, A. Bernardo, Denise King and P. Hudson
Household Size and the Decision to Purchase Health Insurance in Cambodia: Results of a Discrete-Choice Experiment with Scale Adjustment pp. 195-204 Downloads
Sachiko Ozawa, Simrun Grewal and John F.P. Bridges
The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke’s Encephalopathy Presenting at the Emergency Department pp. 205-215 Downloads
Edward C. F. Wilson, George Stanley and Zulfiquar Mirza
Formal Professional Relationships Between General Practitioners and Specialists in Shared Care: Possible Associations with Patient Health and Pharmacy Costs pp. 217-227 Downloads
Ágnes Lublóy, Judit Lilla Keresztúri and Gábor Benedek
Effectiveness and Cost of a Personalized Reminder Intervention to Improve Adherence to Glaucoma Care pp. 229-240 Downloads
Laura T. Pizzi, Judie Tran, Anousheh Shafa, Michael Waisbourd, Lisa Hark, Ann P. Murchison, Yang Dai, Eileen L. Mayro and Julia A. Haller
Comment on: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011” pp. 241-241 Downloads
Afschin Gandjour
Authors’ Reply to Gandjour: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011” pp. 243-243 Downloads
Kenneth E. Thorpe, Lindsay Allen and Peter Joski

Volume 14, issue 1, 2016

The End of the International Reference Pricing System? pp. 1-8 Downloads
Ulf Persson and Bengt Jönsson
Why ‘Optimal’ Payment for Healthcare Providers Can Never be Optimal Under Community Rating pp. 9-20 Downloads
Peter Zweifel and Harry Frech
Variation in Clinical Practice: A Priority Setting Approach to the Staged Funding of Quality Improvement pp. 21-27 Downloads
Jonathan Karnon, Andrew Partington, Matthew Horsfall and Derek Chew
Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA pp. 29-40 Downloads
Axel C. Mühlbacher and Anika Kaczynski
Sherlock 3CG® Tip Confirmation System for Placement of Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance pp. 41-49 Downloads
Megan Dale, Ailish Higgins and Grace Carolan-Rees
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers pp. 51-65 Downloads
Marije Oosterhoff, Marloes E. Maas and Lotte M. G. Steuten
Clinical Practice Variation Needs to be Considered in Cost-Effectiveness Analyses: A Case Study of Patients with a Recent Transient Ischemic Attack or Minor Ischemic Stroke pp. 67-75 Downloads
Leander R. Buisman, Adriana J. Rijnsburger, Heleen M. den Hertog, Aad Lugt and William K. Redekop
Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation pp. 77-87 Downloads
Ataru Igarashi, Rei Goto, Kiyomi Suwa, Reiko Yoshikawa, Alexandra J. Ward and Jörgen Moller
Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness pp. 89-104 Downloads
Donna Rowen, John Brazier, Anju Keetharuth, Aki Tsuchiya and Clara Mukuria
The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial pp. 105-115 Downloads
Darren K. Burns, Edward C. F. Wilson, Paula Browne, Sandra Olive, Allan Clark, Penny Galey, Emma Dix, Helene Woodhouse, Sue Robinson and Andrew Wilson
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists” pp. 117-118 Downloads
Carl Samuelsen, Eric D. Bateman, Ian Pavord, Adam Lloyd, Mike Baldwin and Dirk Esser
Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists pp. 119-125 Downloads
Jenny Willson, Eric D. Bateman, Ian Pavord, Adam Lloyd, Tania Krivasi and Dirk Esser
Page updated 2017-08-16